Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
about
A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa.Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolatesSynergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.Antibiotic combinations: should they be tested?Early synergistic interactions between amikacin and six beta-lactam antibiotics against multiply resistant members of the family Enterobacteriaceae.Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilliAntimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone.Mechanism of action, antimicrobial activity, pharmacology, adverse effects, and clinical efficacy of cefotaxime.Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.Early synergistic interaction between semisynthetic penicillins and aminoglycosidic aminocyclitols against Enterobacteriaceae.Secondary Metabolites Produced by Heterorhabditis Symbionts and Their Application in Agriculture: What We Know and What to Do Next.Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy.
P2860
Q34707883-ADDF3DFE-6BF5-44DB-96A3-34E0EB5B3D47Q35574121-F2B09610-CAF6-4647-98E5-A06A1896DA0DQ35713674-73B50D6C-2331-4F17-BDF7-770E84B23B16Q35761083-47FA79D0-CD9A-4934-B99C-B6E53F63317CQ35761805-7A0B9D68-481F-490B-A452-16DF1299979CQ36632795-BBAD9DE7-7D97-4029-A941-C4DCD3167EF3Q39833523-C49B0692-242C-451F-89C7-0F93802C3679Q39857307-C2F8F5E6-6A13-4171-9B22-B6B1190D6415Q40114571-9DD7DF30-B5F7-4F7C-AAF8-D7B5BCC6CC51Q40134639-EAB88339-0610-4D79-87FF-29D9514474EDQ41963259-3551A722-BEA2-46A3-B729-79C7C14FD275Q42108953-06C90485-0205-4A7A-B397-D6DA8933C27FQ42113634-D0DB96D1-7855-4E3B-B863-0CA05A20E4C7Q42928358-0943BE5C-0BB9-44AD-B075-D9BBAF486BF2Q42929022-58350BA5-79F5-4B9A-8A6E-DC40C80C73B0Q49515629-DC4954B1-765E-45C2-9FC5-2B8539819705Q54200563-2BA63F11-5719-4AB8-B7DC-1498BC79C259
P2860
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Comparative in vitro synergist ...... inosa and Serratia marcescens.
@en
Comparative in vitro synergist ...... inosa and Serratia marcescens.
@nl
type
label
Comparative in vitro synergist ...... inosa and Serratia marcescens.
@en
Comparative in vitro synergist ...... inosa and Serratia marcescens.
@nl
prefLabel
Comparative in vitro synergist ...... inosa and Serratia marcescens.
@en
Comparative in vitro synergist ...... inosa and Serratia marcescens.
@nl
P2093
P2860
P356
P1476
Comparative in vitro synergist ...... inosa and Serratia marcescens.
@en
P2093
P2860
P304
P356
10.1128/AAC.20.2.239
P407
P577
1981-08-01T00:00:00Z